Aveanna Healthcare (AVAH)
(Delayed Data from NSDQ)
$3.71 USD
+0.44 (13.46%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $3.70 -0.01 (-0.27%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AVAH 3.71 +0.44(13.46%)
Will AVAH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AVAH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVAH
The Pennant Group, Inc. (PNTG) Tops Q2 Earnings and Revenue Estimates
Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year?
AVAH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Best Momentum Stocks to Buy for July 12th
Is Aveanna Healthcare (AVAH) Outperforming Other Medical Stocks This Year?
Compared to Estimates, Aveanna (AVAH) Q1 Earnings: A Look at Key Metrics
Other News for AVAH
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday
Aveanna Announces Second Quarter 2024 Earnings Release Date and Conference Call
Aveanna Healthcare Enhances Investor Communication with Presentation
Aveanna to Participate at the UBS Healthcare Services Cape Cod Summit and Jefferies Global Healthcare Conference